Strength
10 mg/.5mL
Manufacturer
Eli Lilly and CompanyNDC
00002247180
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
TIRZEPATIDEApproval Type
New Drug (NDA)
FDA Application
NDA217806On Market Since
11/8/2023
Pharmacological Classes
G-Protein-linked Receptor Interactions
GLP-1 Receptor Agonist
Glucagon-like Peptide-1 (GLP-1) Agonists
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Related Drugs
Same classification
RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1602
per EA
RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1671
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1730
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0731
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8558
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7373
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8351
per ML
OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN
Brand
00169477212•Novo Nordisk
$331.9569
per ML
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN
Brand
00169413013•Novo Nordisk
$331.9930
per ML